RUO Rapid Test for Respiratory Co-Infections and AR Pathogens
The test is designed to detect respiratory co-infections as well as antibiotic-resistant pathogens in patients with SARS-CoV-2.
Read MorePosted by Laurie Bonner | Oct 22, 2020 | Covid 19, Molecular Diagnostics |
The test is designed to detect respiratory co-infections as well as antibiotic-resistant pathogens in patients with SARS-CoV-2.
Read MorePosted by Laurie Bonner | Oct 21, 2020 | Company News, Digital Pathology |
End-to-end transformation will enable groundbreaking biomedical research, advance precision medicine initiatives, and improve routine diagnosis.
Read MorePosted by Melanie Hamilton-Basich | Oct 20, 2020 | Covid 19, Mass Spectrometry |
The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.
Read MorePosted by Laurie Bonner | Oct 19, 2020 | Covid 19, Hematology & Serology |
The team tested alternative ways to measure covid-19 antibody levels, resulting in a process that is faster, easier, and less expensive to use on a large scale.
Read MorePosted by Laurie Bonner | Oct 13, 2020 | Compliance, Covid 19, Flu & Respiratory Infections |
The FDA has issued and immediately implemented a new guidance: Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency.
Read More